New pain block study for shoulder surgery: does the expensive version work better?
NCT ID NCT05900427
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study looked at two different nerve blocks to manage pain after shoulder replacement surgery. One group received a standard painkiller (bupivacaine), while the other got a mix that included a longer-acting version (liposomal bupivacaine). The goal was to see which approach led to better pain control and less need for opioids in the days after surgery. The study was stopped early and enrolled 78 adults aged 18-90.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
78 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject ages 18-90 years old * Male or Female subjects * Weight ≥ 60 kg. * Must be able to consent in English Exclusion Criteria: * Ages: \<18 and \>90 * Weight \< 60 kg * Multiple surgeries during one hospital stay * Emergency surgery * Allergy or any contraindication to local anesthetics used in trial. * Pregnancy * Contraindicated for use of liposomal bupivacaine * Severe liver/kidney disease * Defined as a diagnosis of end-stage renal disease (ESRD) defined as being on dialysis * Subject who received another local anesthetic block prior to the interscalene block. * Unable to consent in English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Reverse total shoulder arthroplasty are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NorthShore University HealthSystem
Skokie, Illinois, 60076, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New shoulder implant put to the test against standard replacement
- Can a 48-Hour nerve block prevent the 'Rebound Pain' after shoulder surgery?
- Iodine-coated surgical drapes may cut infection risk in shoulder replacements
- Shoulder surgery showdown: does removing a tiny bone fragment boost recovery?
- Can a smartphone app get you back on your feet faster after shoulder surgery?
- New nerve block aims to slash opioid use after shoulder surgery